Latest Clive D. Svendsen Stories

NEW YORK (Reuters Health) - Genetically modified nerve 'progenitor' cells can be used as mini-pumps to deliver nerve growth factor to the brain, a new study in animals shows. The results suggest such an approach could be used to treat Parkinson's disease and other brain diseases in humans, Dr. Clive D. Svendsen of the University of Wisconsin-Madison and colleagues report. A nerve growth factor called "glial cell line-derived neurotrophic factor" (abbreviated to GDNF) has been shown to...